MarketPulse
I

$ISRG

11 articles found
6 positive
2 negative
3 neutral
The Motley FoolThe Motley Fool··Adria Cimino

Two Defensive Healthcare Plays for Uncertain Markets: Abbott and Intuitive Surgical

Abbott Laboratories and Intuitive Surgical offer defensive healthcare positioning through diversification, dividend stability, and recurring revenue models amid market uncertainty.
ABTISRGhealthcaredividend growth
BenzingaBenzinga··Vandana Singh

FDA Issues Safety Alert Over Intuitive Surgical Stapler Failures in da Vinci System

FDA alerts to safety defects in Intuitive Surgical's da Vinci staplers causing incomplete staple lines, one death, and four injuries. Company directs hospitals to remove affected devices immediately.
ISRGpatient safetyFDA safety alert
GlobeNewswire Inc.GlobeNewswire Inc.··Healthcare Foresights

Surgical Stapling Devices Market to Nearly Double to $10.1B by 2035

Global surgical stapling devices market valued at $5.47B in 2025, projected to reach $10.14B by 2035, growing 7.2% annually driven by minimally invasive procedures and obesity.
JNJMDTISRGSNNhealthcare technologymarket growth
The Motley FoolThe Motley Fool··Daniel Sparks

Intuitive Surgical Faces Valuation Crossroads After Strong Q4 Results

Intuitive Surgical posted strong Q4 results with 19% revenue growth, but 2026 guidance signals meaningful deceleration. At 63x earnings, stock appears fairly valued for current shareholders but overvalued for new investors.
ISRGmedical devicesvaluation risk
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Surgical Robots and Glucose Monitors Positioned for Decade-Long Growth Despite Competition

Intuitive Surgical and DexCom positioned for long-term growth despite near-term competition, driven by aging populations and untapped market opportunities.
MDTDXCMISRGlong-term investinggrowth stocks
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Healthcare Giants BDX and MDT Offer Dividend Appeal Below $1,000 Each

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.
MDTISRGBDXdividend stockslong-term investing
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Medtronic's FDA-Approved Hugo Robot Could Unlock Major Growth as Valuation Gap Widens

Medtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield.
MDTISRGgrowth opportunityvaluation
The Motley FoolThe Motley Fool··Selena Maranjian

Medtronic Strengthens Market Position With Hugo Robotics Entry and Diabetes Spinoff

Medtronic gains FDA approval for Hugo robotic surgery system and spins off diabetes division, strengthening market position while reporting 8.7% revenue growth and maintaining 48-year dividend streak.
MDTISRGFDA approvaldividend growth
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Intuitive Surgical Positioned for Long-Term Growth Despite Near-Term Pressures

Intuitive Surgical faces near-term headwinds but maintains strong long-term growth potential through its dominant robotic surgery platform, structural competitive advantages, and expanding market opportunities.
ISRGtariffscompetitive moat
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Intuitive Surgical Posts Double-Digit Growth Despite GLP-1 Drug Market Spotlight

Intuitive Surgical posts double-digit growth in 2025 with 12% installed base expansion and 18% surgery increase, unaffected by GLP-1 drug market competition.
LLYNVOISRGGLP-1 drugsgrowth stocks
The Motley FoolThe Motley Fool··Adria Cimino

Intuitive Surgical's Market Resilience Rooted in Surgical Automation Dominance

Intuitive Surgical dominates robotic surgery market with resilient recurring revenue from instruments and services, insulating it from economic downturns.
ISRGhealthcare stockscompetitive moat